- Home
- HUIZ vs DYAI Comparison
HUIZ vs DYAI Comparison
Compare HUIZ & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HUIZ | DYAI |
|---|---|---|
| Founded | 2006 | 1979 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5M | 29.9M |
| IPO Year | 2020 | 2004 |
Fundamental Metrics
Financial Performance| Metric | HUIZ | DYAI |
|---|---|---|
| Price | $3.21 | $0.95 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.30 | ★ $3.00 |
| AVG Volume (30 Days) | 7.8K | ★ 501.4K |
| Earning Date | 03-24-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $186,519,166.00 | $3,342,195.00 |
| Revenue This Year | $22.67 | $12.52 |
| Revenue Next Year | $8.55 | $92.04 |
| P/E Ratio | $12.65 | ★ N/A |
| Revenue Growth | ★ 19.12 | N/A |
| 52 Week Low | $1.50 | $0.71 |
| 52 Week High | $4.53 | $2.14 |
Technical Indicators
Market Signals| Indicator | HUIZ | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 44.38 | 49.19 |
| Support Level | $3.04 | $0.80 |
| Resistance Level | $3.58 | $1.04 |
| Average True Range (ATR) | 0.28 | 0.08 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 21.88 | 63.14 |
Price Performance
Historical ComparisonAbout HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.